HK Stock MarketDetailed Quotes
02157 LEPU BIO-B
- 2.810
- -0.240-7.87%
Market Closed Nov 22 16:08 CST
4.81BMarket Cap-59787P/E (TTM)
3.130High2.780Low4.48MVolume3.130Open3.050Pre Close13.00MTurnover0.27%Turnover RatioLossP/E (Static)1.71BShares6.50052wk High4.80P/B4.65BFloat Cap2.16052wk Low--Dividend TTM1.66BShs Float31.800Historical High--Dividend LFY11.48%Amplitude2.160Historical Low2.904Avg Price1000Lot Size--Div YieldTTM--Div Yield LFY
LEPU BIO-B Key Stats
All
YOY
| (Q6)Jun 30, 2024 | (FY)Dec 31, 2023 | (Q6)Jun 30, 2023 | (FY)Dec 31, 2022 | (Q6)Jun 30, 2022 | (FY)Dec 31, 2021 | (Q6)Jun 30, 2021 | (FY)Dec 31, 2020 | (FY)Dec 31, 2019 | |
|---|---|---|---|---|---|---|---|---|---|
| Cash flow from operating activities | |||||||||
| Earning before tax | ---- | 95.67%-30.3M | ---- | 32.02%-699.44M | ---- | -67.72%-1.03B | ---- | -19.00%-613.45M | ---515.49M |
| Profit adjustment | |||||||||
| Investment loss (gain) | ---- | -15.17%27.34M | ---- | 152.95%32.23M | ---- | 82.21%12.74M | ---- | 5.32%6.99M | --6.64M |
| Impairment and provisions: | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --372K |
| -Other impairments and provisions | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --372K |
| Revaluation surplus: | ---- | -379.54%-175.1M | ---- | -17.89%62.64M | ---- | -2.19%76.29M | ---- | 103.57%77.99M | --38.31M |
| -Other fair value changes | ---- | -379.54%-175.1M | ---- | -17.89%62.64M | ---- | -2.19%76.29M | ---- | 103.57%77.99M | --38.31M |
| Asset sale loss (gain): | ---- | -16,984.54%-103.87M | ---- | 88.68%-608K | ---- | ---5.37M | ---- | ---- | ---70K |
| -Loss (gain) from sale of subsidiary company | ---- | ---103.87M | ---- | ---- | ---- | ---5.37M | ---- | ---- | ---- |
| -Loss (gain) on sale of property, machinery and equipment | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---70K |
| -Loss (gain) from selling other assets | ---- | ---- | ---- | ---608K | ---- | ---- | ---- | ---- | ---- |
| Depreciation and amortization: | ---- | 7.47%102.57M | ---- | 0.21%95.45M | ---- | 13.23%95.25M | ---- | 70.73%84.11M | --49.27M |
| -Amortization of intangible assets | ---- | 1.75%29.79M | ---- | 1.14%29.28M | ---- | 1.39%28.95M | ---- | 6.57%28.55M | --26.79M |
| Financial expense | ---- | 116.77%6.45M | ---- | -4,101.25%-38.45M | ---- | -98.80%961K | ---- | 53.88%79.9M | --51.93M |
| Special items | ---- | -419.59%-97.66M | ---- | -73.01%30.56M | ---- | 1,983.15%113.24M | ---- | -96.22%5.44M | --143.7M |
| Operating profit before the change of operating capital | ---- | 47.73%-270.58M | ---- | 29.65%-517.63M | ---- | -104.94%-735.77M | ---- | -59.31%-359.01M | ---225.35M |
| Change of operating capital | |||||||||
| Inventory (increase) decrease | ---- | -4,450.41%-5.35M | ---- | 102.67%123K | ---- | 59.82%-4.62M | ---- | -42.13%-11.49M | ---8.08M |
| Accounts receivable (increase)decrease | ---- | -226.91%-32.98M | ---- | 227.60%25.99M | ---- | 73.25%-20.37M | ---- | -64.26%-76.15M | ---46.36M |
| Accounts payable increase (decrease) | ---- | 1,858.85%50.03M | ---- | -98.10%2.55M | ---- | 618.60%134.56M | ---- | -43.94%18.73M | --33.4M |
| Special items for working capital changes | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --12M |
| Cash from business operations | -45.48%-117.27M | 47.05%-258.89M | 58.54%-80.61M | 21.91%-488.96M | 45.63%-194.42M | -46.33%-626.19M | ---357.59M | -82.57%-427.92M | ---234.39M |
| Interest received - operating | -57.23%2.14M | 0.21%8.05M | 206.30%5.01M | 80.37%8.03M | -50.29%1.64M | -14.86%4.45M | --3.29M | 1,220.71%5.23M | --396K |
| Net cash from operations | -52.29%-115.13M | 47.84%-250.84M | 60.79%-75.6M | 22.65%-480.93M | 45.59%-192.78M | -47.09%-621.74M | ---354.3M | -80.64%-422.69M | ---233.99M |
| Cash flow from investment activities | |||||||||
| Decrease in deposits (increase) | ---- | ---- | ---- | 268.71%50.61M | 268.71%50.61M | -50.00%-30M | ---30M | ---20M | ---- |
| Sale of fixed assets | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --771K | ---- |
| Purchase of fixed assets | 31.78%-12.16M | 74.65%-28M | 71.07%-17.82M | 48.24%-110.45M | 40.49%-61.6M | 10.82%-213.39M | ---103.51M | 24.87%-239.26M | ---318.47M |
| Purchase of intangible assets | -180.04%-11.46M | -163.94%-13.2M | ---4.09M | 18.25%-5M | ---- | 90.41%-6.12M | ---- | -40.54%-63.75M | ---45.36M |
| Sale of subsidiaries | ---- | --125M | ---- | ---- | ---- | --10M | ---- | ---- | ---- |
| Acquisition of subsidiaries | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---19.57M | ---- |
| Recovery of cash from investments | ---- | 6.27%50.14M | ---- | -96.78%47.18M | -96.41%37.16M | 9.90%1.46B | --1.03B | 160.53%1.33B | --511.54M |
| Cash on investment | ---- | -6.38%-50M | ---- | 95.84%-47M | 95.65%-37M | 33.22%-1.13B | ---850M | -225.42%-1.69B | ---519.5M |
| Other items in the investment business | ---- | -556.81%-65.68M | ---65M | 90.00%-10M | ---- | -100.00%-100M | ---- | -14.89%-50M | ---43.52M |
| Net cash from investment operations | 72.82%-23.62M | 124.45%18.26M | -702.75%-86.91M | -1,818.37%-74.66M | -121.42%-10.83M | 99.48%-3.89M | --50.55M | -80.50%-749.67M | ---415.32M |
| Net cash before financing | 14.62%-138.75M | 58.14%-232.58M | 20.18%-162.51M | 11.19%-555.59M | 32.97%-203.61M | 46.64%-625.63M | ---303.75M | -80.55%-1.17B | ---649.31M |
| Cash flow from financing activities | |||||||||
| New borrowing | 26.65%295.54M | -7.75%403.55M | 67.21%233.35M | 199.40%437.46M | --139.56M | 34.05%146.11M | ---- | -7.83%109M | --118.27M |
| Refund | -94.13%-260.21M | -343.72%-359.31M | -1,240.39%-134.04M | -16,095.20%-80.98M | ---10M | 99.38%-500K | ---- | -133.85%-80M | ---34.21M |
| Issuing shares | --213.38M | ---- | ---- | --739.23M | --739.23M | ---- | ---- | ---- | ---- |
| Interest paid - financing | 9.52%-14.02M | -37.30%-29.38M | -97.66%-15.49M | -130.27%-21.39M | -86.15%-7.84M | 26.81%-9.29M | ---4.21M | -1,731.89%-12.7M | ---693K |
| Absorb investment income | ---- | ---- | ---- | ---- | ---- | -81.28%261.12M | --261.12M | 321.81%1.39B | --330.6M |
| Issuance expenses and redemption of securities expenses | ---3.44M | 96.53%-1.2M | ---- | -1,803.63%-34.57M | -1,667.75%-30.97M | ---1.82M | ---1.75M | ---- | ---- |
| Other items of the financing business | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --358.12M |
| Net cash from financing operations | 205.13%225.99M | -101.07%-11.01M | -91.05%74.06M | 171.35%1.03B | 240.27%827.82M | -72.57%380.31M | --243.29M | 80.00%1.39B | --770.39M |
| Effect of rate | -24.90%389K | -99.44%212K | -98.52%518K | 1,689.88%37.86M | 3,087.91%35.11M | -238,200.00%-2.38M | ---1.18M | 0.00%1K | --1K |
| Net Cash | 198.63%87.24M | -151.14%-243.59M | -114.17%-88.45M | 294.19%476.37M | 1,132.37%624.21M | -214.46%-245.32M | ---60.46M | 77.00%214.32M | --121.08M |
| Begining period cash | -36.36%426.02M | 331.40%669.4M | 331.40%669.4M | -61.48%155.17M | -61.48%155.17M | 113.67%402.87M | --402.87M | 179.48%188.55M | --67.46M |
| Cash at the end | -11.66%513.64M | -36.36%426.02M | -28.61%581.46M | 331.40%669.4M | 138.69%814.49M | -61.48%155.17M | --341.23M | 113.67%402.87M | --188.55M |
| Cash balance analysis | |||||||||
| Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
| Accounting Standards | IAS | IAS | IAS | IAS | IAS | IAS | IAS | IAS | IAS |
| Audit Opinions | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | Unqualified Opinion |
| Auditor | -- | PricewaterhouseCoopers | -- | PricewaterhouseCoopers | -- | PricewaterhouseCoopers | -- | PricewaterhouseCoopers | PricewaterhouseCoopers |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.
Analysis
Price Target
No Data
Heat List
HK
Overall
Symbol
Latest Price
% Chg
No Data